Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of Adacel against pertussis disease in infants < 2 months when administered during pregnancy following the current Advisory Committee on Immunization Practices (ACIP) recommendations, i.e., from 27 to 36 weeks of gestation, and 14 days or more before delivery.


Clinical Trial Description

The original study included cases recorded from 01 January 2011 through 31 December 2014, based on retrospective case-control methodology. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05040802
Study type Observational
Source Sanofi
Contact
Status Active, not recruiting
Phase
Start date June 2, 2021
Completion date September 20, 2021